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Abstract
Background: To examine whether electro-acupuncture (EA) could decrease 5-hydroxytryptamine (5-HT) and
calcitonin gene-related peptide (CGRP), and increase neuro-peptide Y (NPY) in the brain-gut axis (BGA) in D-IBS
using rat models.
Methods: Rats were randomly exposed to unpredictable chronic stress for 3 weeks followed by 1-hour acute
restraint stress (CAS) after 7 days of rest, or daily gavage of Senna decoction (6 g/kg) plus chronic restraint stress
(for a duration of 2 h, starting from 1 h prior to the gavage) for 2 weeks (ISC). The content of 5-HT, CGRP and NPY
in the distal colon, spinal cord, hypothalamus was examined at the end of the treatment.
Results: 1. The two rat models exhibited similar characteristics, e.g., increased number of fecal pellets expelled in
1 h, decreased sacchar-intake, decreased CRD, elevated 5-HT, CGRP content and decreased NPY in the distal colon,
spinal cord, hypothalamus (P < 0.05 vs. that in healthy control rats). 2. A series of equations was developed based
on correlation regression analysis. The analysis results demonstrated that 5-HT mediates the changes in
hypothalamus, spinal cord and colon. 5-HT and CGRP in spinal cord was closely correlated with general behavior
evaluation and other transmitters in BGA.
Conclusion: 1. In comparison to 5-HT, CGRP and NPY (particularly in the spinal cord) had closer relationship with
the D-IBS symptoms induced by either stress factors or Senna decotion.
2. EA treatment could restore the brain-gut axis to balanced levels.
Keywords: Diarrhea-predominant irritable bowel syndrome (D-IBS), Brain-gut axis (BGA), Electro-acupuncture (EA),
5-hydroxytryptamine (5-HT), Calcitonin gene-related peptide (CGRP), Neuro-peptide Y (NPY)
Background/Introduction
Diarrhea-predominant irritable bowel syndrome (D-IBS)
is one of the most common subtypes of IBS. The causes
may include stress (both psychological and social) and
dietary factors. Medications that alter the function of the
gastrointestinal (GI) tract may also cause D-IBS. The
symptoms of the disorder aggravate the stress, thus form-
ing a vicious cycle. Many types of managements (including
medications) are available to treat this disease, but all have
limited efficacy.
A previous study from this research group [1] showed
that electro-acupuncture (EA) could lower the severity
and frequency of abdominal pain, diarrhea, abdominal dis-
tension, and increase the quality of life (QOL) in patients
with IBS. Besides, acupuncture therapy also showed good
regulation on the important influencing factors of IBS, as
anxiety, conflict behavior, dietary restriction and social
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response, etc. Some relevant experiments and study about
D-IBS found that acupuncture could regulate central ner-
vous system, immune system, endocrine system and GI
tract, particularly the excitability of brain functional areas
and dorsale medullae spinalis neurons [2]. So is the effect
of acupuncture on IBS just placebo effect, or real curative
effect such as alleviation of the intestinal tract symptoms,
regulation of psychological symptoms? Are there any dif-
ferences of the effects on model rats between the induce-
ments of stress factor and food-medicine factor? Are there
any congenerous paths on mechanism and what’s their
correlation?
Most existing methods of making model are trying to
combine more than two stimulating methods in order
to simulate IBS’s onset characteristics comprehensively
but there is still no affirmative conclusion. We com-
bined kinds of accepted stimulating methods and
simulated two important inducements of IBS’s onset
characteristics, stress factor and food-medicine factor.
In the current study, we used two rat models of D-IBS
to examine the potential efficacy of EA. Animal behav-
iors that reflect the disease phenotype and neurotrans-
mitters (5-HT, CGRP, NPY) in the brain-gut axis (BGA)
were examined. We made up two kinds of models, and
tried to analyze the mechanism of IBS model rats’ BGA
system modification by two stimulating methods and
the effectiveness of EA interference on IBS.
Methods
Ethics statement
All procedures had the approval of the Animal Ethics
Committee of the Nanjing University of Chinese Medicine.
D-IBS and treatment
Wistar rats (100 ~ 120 g, four weeks of age, consisting
of both genders at a ratio of 1:1) were housed indi-
vidually in a specific-pathogen-free facility (22 ± 2 °C),
under a 12/12 h light/dark cycle (lights on from
6:00 am). Standard rat food and tap water were avail-
able without restriction unless otherwise noted. After
1-week acclimation, rats were randomly exposed to
one of the following conditions: unpredictable chronic
stress for 3 weeks followed by 7 days of rest and then
1-h acute restraint stress (rat model of chronic and
acute stress, CAS) [3], or daily gavage of senna decoc-
tion (6 g/kg) plus chronic restraint stress (for a dur-
ation of 2 h, starting from 1 h prior to the gavage) for
2 weeks (rat model of senna gavage and chronic, ISC)
[4]. Food (but not water) was removed 10 h prior to the
exposure. The unpredictable chronic stress included the
following seven stressors at random order: overnight illu-
mination for 12 h, 45 °C environment for 5 min, water
deprivation for 24 h, 4 °C environment for 3 min, tail
clamp for 1 min, level vibration (120/min) for 40 min, and
food deprivation for 24 h. Behavior testing was conducted
between 8.00 am and 12.00 am. Defecation was examined
by counting the number of fecal pellets in a period of 1 h.
Sacchar (1 % sucrose) intake and abdominal withdrawal
reflex (AWR) were also examined at the end of the
experiments.
Part of the rats received EA treatment (15-min daily
session for a duration of 2 weeks), starting from the sec-
ond day after the exposure, using a paradigm described
below.
Rats were immobilized using a homemade board. EA
was delivered to the following sites bilaterally at a depth
of 3-mm under aseptic condition: ST25 (tianshu), ST36
(zusanli), and LR3 (taichong), using disposable Huatuo
acupuncture needles for cosmetic use (0.19 mm ×
10 mm; Suzhou Medical Appliance Factory; Suzhou,
China) [5]. EA was delivered using a stimulator for
15 min (HANS-200A, Nanjing Jisheng Medical Technol-
ogy Co., Ltd., China) in alternating trains of dense-
sparse rectangular stimuli (2/15 Hz, 0.8 ~ 1.3 mA).
Colonic motility was examined by counting the num-
ber of fecal pellets for a period of 1 h. Sacchar (1 %
sucrose) intake was used to reflect anhedonia, as de-
scribed previously. AWR was examined in response to
colorectal distention (CRD), as explained below. A poly-
ethelene balloon (length: 1.5 cm; diameter: 0.9 cm) was
inserted into the descending colon. The rat was placed
on a 20 × 8 × 8 cm platform and allowed to adapt for
15 min. Measurement with each fluid volume in the bal-
loon to induce AWR lasted 10 s, and was repeated for
three times, with 10-min interval.
A separate group of rats were included as a healthy
control. The number of the animal subjects was 12–16
per group.
Group 1: CAS model of D-IBS Without EA;
Group 2: CAS model of D-IBS With EA;
Group 3: ISC model of D-IBS Without EA;
Group 4: ISC model of D-IBS With EA;
Group 5: Heathy Control.
Measurement of 5-HT, CGRP, and NPY
Rats were sacrificed under deep anesthesia with ur-
ethane (6 ml/kg, ip); the hypothalamus, spinal cord
(lumbar intumescentia, L4-L6), and distal colon (at 8-
cm proximal to colorectal junction) were excised and
stored at −80 °C for analysis of 5-HT, CGRP and NPY
content using enzyme linked immunosorbentassay
(ELISA; all from R&D rat 5-Hydroxytryptamine (5-HT)
& Calcitonin Gene Related Peptide (CGRP) & Neuro-
peptide Y (NPY) elisa kits provided by Nanjing jian-
cheng bioengineering institute). Distal colon was also
fixed in neutral formalin for paraffin embedding,
followed by HE staining and microscopic examination.
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Data analysis
One-way ANOVA or Kruskal Wallis Tests among groups
was used to interpret the data for significant differences,
the data were expressed as mean ± Standard deviation.
Pearson’s correlation test was used to analyze the potential
correlation between 5-HT, CGRP and NPY content in the
hypothalamus, spinal cord and distal colon and behavioral
measures, such as colonic motility, psychological ethology
and colonic sensation. All analyses were carried out using
SPSS version 17.0 (SPSS, Chicago, IL, USA). Statistically
significant differences were defined at P < 0.05.
Results
Five rats (one in CAS rats with EA, two each in CAS and
ISC rats without EA) developed macro- or micro- intestinal
bleeding, and were not included in data analysis. Otherwise,
microscopic examination revealed healthy colon mucous
membrane structure, including cryptae, epidermis and all
other tissues.
1. Comparison between groups
Because the data of the five groups didn’t accord with
normal distribution and homogeneity of variance, we chose
the statistic method of Kruskal Wallis Test to explore the
comparison of general behavioral evaluation distribution
between groups.
Body weight, fecal pellet number, loose stool rate and
sacchar-intake at baseline did not differ between the two
paradigms (P > 0.05; Fig. 1a, b, c, d, e). Starting from one
week after its implementation, chronic stress decreased the
body weight (P < 0.05 between CAS and ISC paradigms).
EA decreased the body weight significantly (P < 0.05).
Fecal pellet number was increased by chronic stress
(P < 0.05 vs. the healthy control, Fig. 1d). The EA treat-
ment decreased the fecal pellet number under both condi-
tions to a level comparable to the healthy control (P > 0.05
vs. the healthy control). EA decreased the number of fecal
pellets in CAS rats and ISC rats.
Effects of the behavioral paradigms and EA on loose
stool rate were generally similar to that in the number of
fecal pellets. However, the loose stool rate was higher in
ISC rats, with or without EA, in comparison to that in
CAS rats, indicating that Senna leaf could induce loose
stool (Fig. 1e).
The stress decreased sacchar-intake in CAS rats and
ISC rats (P < 0.05 vs. healthy control). EA treatment
incerased sacchar-intake to a level comparable to the
healthy control (P > 0.05 vs. the healthy control) (Fig. 1c).
Both the CAS group and ISC group have a lower CRD
value (P < 0.05 vs. healthy control), and EA treatment
increased CRD (P < 0.05 vs. CAS group and ISC without
EA) to a level comparable to that in the healthy control
(Fig. 1f ).
The CAS and ISC rats had higher 5-HT, CGRP content
and lower NPY content in the colon, the spinal cord, the
hypothalamus (P < 0.05 vs. healthy control). EA decreased
5-HT and CGRP content in the distal colon, spinal cord,
hypothalamus in both CAS and ISC rats (P < 0.05, vs.
CAS group and ISC without EA). NPY content was
increased by EA (P < 0.05, vs. CAS group and ISC without
EA) to levels comparable to that in the healthy control
rats (P > 0.05, vs. healthy control). EA treatment reduced
5-HT, CGRP content and increased NPY content in both
CAS and ISC rats (Fig. 1g, h, i).
2. Analysis of the coefficient correlation between
factors
Body weight was higher in male rats. Sacchar-intake
correlated negatively with the number of fecal pellets
(r = −0.694) and CGRP content of the spinal cord
(r = −0.668).
A regression analysis revealed the following equation:
CRD = 0.095 + 0.285 X, in which X is AWR level (1–4)
(R = 0.837, r2 = 0.700). The adjusted coefficient of deter-
mination (r2) was 0.699. T was 3.032 and 24.899 and P
was 0.003 and <0.001, respectively upon t-test (P < 0.05).
5-HT content in distal colon, spinal cord, hypothalamus
could be described as Y = 54.683 + 0.216X1 + 0.416X2, in
which X1 is 5-HT content of hypothalamus, and X2 is 5-
HT content of spinal cord. The coefficient of regression of
X1 and X2 is 0.216 and 0.416, respectively (Table 1). T was
2.242, 2.899 and 3.077 respectively, whereas P was 0.028,
0.005 and 0.003, respectively upon t-test. R = 0.566, r2 =
0.321 and the coefficient of determination was 0.299. NPY
content of colon was proportional to CGRP content of
colon and spinal cord (R = 0.652, r2 = 0.425, R2 = 0.397),
and could be described using the following equation: Y =
1240.389 + 45.471X1-37.872X2, in which the NPY content
of colon and X1 and X2 are CGRP content of colon and
spinal cord respectively. The regression coefficient was
45.471 and −37.872, respectively. T was 9.623, 4.890
and −5.183 whereas P was <0.001 for all. The exclusion
coefficient was 0. T value for regression between the
CGRP content of hypothalamus and the NPY content
of colon was −0.872 (P = 0.387). The possibility of T at
0 could not be excluded. Other regression equations
(Table 1) are in accordance with the above analysis.
3. Total Variance Explained and factor analysis
On the basis of the correlation matrix, a principle com-
ponent analysis was carried out to examine. The results
showed that total variance explained five characteristic
value were >1, with a cumulative dedication rate at 76.48 %.
The least cumulative dedication rate was 81.6 %. Factor
significance was f1 > f2 > f3 > f4 > f5 > f6 . With component
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matrix = ±0.5 as weight, CGRP of spinal cord, CRD meas-
urement, fecal pellets, sacchar-intake amount, CGRP of
hypothalamus, CGRP of distal colon, 5-HT of spinal cord,
NPY of hypothalamus were significant in the f1 factors.
KMO and Bartlett's test showed that Kaiser-Meyer-
Olkin measure of sampling adequacy (KMO) at 0.804, and
Bartlett's test of sphericity approx Chi-Square at 834.209
(P < 0.01), indicating the suitability of the factor analysis.
Three factors F1, F2 and F3 (F1 > F2 > F3 in importance)
were chosen for a rotated component matrix. F1 had the
highest factor loading in CRD measurement (based on
AWR Level), body weight and CGRP content of spinal
cord. F2 was important in fecal pellet number; 5-HT con-
tent of colon, hypothalamus and spinal cord, CGRP
content of hypothalamus and colon. F3 was important in
the sacchar-intake, NPY content of colon and hypothal-
amus, CGRP and 5-HTcontent of spinal cord.
Discussion
Psychological, character-related, genetic, contagious, and
dietary factors all contribute to the etiology of IBS [6]. D-
IBS patients typically have higher depression score than
healthy control [7]. Food items that could induce D-IBS
commonly include dairy products, chocolate, eggs and
wheat, and more than 50 % patients of D-IBS have a
history of food allergy [8]. In the current study, D-IBS was
simulated using two methods (stress with vs. without
senna decotion). The two methods produced comparable
Fig. 1 Comparison of general bahavioral evaluation distribution (mean±SD)
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Table 1 Analysis of the correlation coefficient between various factors and neuropeptides
Dependent
Variables(Y)





(Y = B0 + B1X1 +





















X is CGRP in spinal cord 0.666 0.444 0.417 Y = −2.916
+ 0.140X
(Constant) −2.916 0.836 −3.489 0.001
CGRP of
spinal cord
0.14 0.047 0.361 2.96 0.004




0.105 0.06 0.195 1.749 0.085
CGRP of
hypothalamus
0.076 0.04 0.239 1.92 0.059
fecal pellets
at 1 h
X1 is 5-HT of colon,
X2 is 5-HT of spinal cord
0.588 0.345 0.325 Y = −2.005 +
0.013X1 + 0.012X2
(Constant) −2.005 0.806 −2.487 0.016
5-HT of colon 0.013 0.004 0.377 3.271 0.002




0.012 0.005 0.304 2.633 0.011
fecal pellets
at 1 h
X is NPY of spinal cord 0.568 0.322 0.29 Y = 9.619-0.003X (Constant) 9.619 1.332 7.221 <0.0001
NPY of spinal
cord
−0.003 0.001 −0.408 −3.762 <0.0001
Excluded Variables: NPY of
colon, hypothalamus
NPY of colon −0.001 0.001 −0.166 −1.421 0.16
NPY of
hypothalamus
0 0.001 −0.18 −1.547 0.127
fecal pellets
at 1 h
X1is CGRP of spinal cord, X2 is
NPY of spinal cord
STEP EXCLUDED Y = 3.367 +
0.202X1-0.003X2
(Constant) 3.367 1.289 2.613 0.011
CGRP of
spinal cord
0.202 0.035 0.521 5.809 <0.0001
NPY of spinal
cord
−0.003 0.001 −0.391 −4.363 <0.0001
Excluded Variables: 5-HT of




.258a 2.349 0.022 0.282 0.769
5-HT of colon .392a 4.267 0 0.471 0.928
NPY of spinal
cord




X is CGRP of spinal cord 0.682 0.466 0.44 Y = 39.289-0.635X (Constant) 39.289 2.195 17.903 <0.0001
CGRP of
spinal cord
−0.635 0.124 −0.61 −5.105 <0.0001




−0.234 0.158 −0.162 −1.478 0.144
CGRP of
hypothalamus




X is 5-HT of spinal cord 0.418 0.175 0.162 Y = 33.278-0.045X (Constant) 33.278 2.229 14.929 <0.0001








X1 is NPY of colon, X2 is NPY
of hypothalamus
0.541 0.292 0.259 Y = 9.175 +
0.005X1 + 0.004X2
(Constant) 9.175 3.648 2.515 0.014
NPY of colon 0.005 0.002 0.279 2.336 0.023




0.004 0.002 0.271 2.275 0.026
NPY of spinal
cord
0.004 0.003 0.171 1.544 0.128
X is CGRP of spinal cord STEP EXCLUDED Y = 37.323-0.696X (Constant) 37.323 1.731 21.567 <0.0001
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changes in colonic motility (increased fecal pellets),
anhedonia (decreased sacchar-intake) and colonic visceral
sensation (decreased CRD measurement). Immunologic
pathology of the colon showed no change.
The two paradigms increased the 5-HT and CGRP, and
decreased NPY content in the hypothalamus to similar de-
grees. Animal behaviors did not differ significantly between
the CAS and ISC rats. EA treatment alleviated the IBS-like
symptoms, and attenuated the changes of 5-HT, CGRP and
NPY in BGA to a level comparable to the control.
5-HT is a major transmitter in BGA. 5-HT receptor
antagonists have been used to manage D-IBS [9], and have
been shown to reduce gastrointestinal motility and viscera
sensitivity [10]. 5-HT receptor antagonists in combination
with agents that target other nuerotransmitters in BGA are
a promising approach [11]. CGRP and its receptors are
enriched in dorsal root ganglion (DRG), and correlate with
visceral hypersensitivity. NPY is a major neurotransmitter
in the enteric plexus, and could affect cholinergic transmis-
sion in intestine mucous membrane inferior ganglion and
regulate stress and mood by affecting hippocampus and
hypothalamus.
In the current study, the correlation regression equations
(Table 1) and linear relation on neurotransmitters in differ-
ent BGA tissues showed that 5-HT but not CGRP and
NPY content in the BGA was linearly correlated to IBS-like
symptoms. However, via the action of 5-HT, both CGRP
and NPY exhibited synchronous changes in hypothalamus
and colon. The content of 5-HT, CGRP and NPY was cor-
related among each other in the colon, but not in the hypo-
thalamus and spinal cord. The 5-HT and CGRP content in
the same tissue was linearly correlated, but not correlated
across hypothalamus, spinal cord and colon. Finally, the
changes of 5-HT and CGRP in spinal cord was closely cor-
related to IBS-like symptoms and NPY in hypothalamus
and colon, suggesting the 5-HT and CGRP in the spinal
cord are important in the development of IBS.
The spinal cord is the relay station between the brain and
gut, and thus critical for the development of IBS mechan-
ism. Our findings support the hypothesis that the spinal
cord is over-active in D-IBS. This could partly explain the
apparent therapeutic action of EA. The exact mechanisms
of action, however, need to be further analyzed.
Conclusions
The two models (ISC vs. CAS) produced comparable IBS-
like symptoms and changes in the BGA in rats. EA treat-
ment could alleviate IBS-like symptoms, encouraging it
clinical use in patients with D-IBS. The results also suggest
that alteration of 5-HT in the brain, spinal cord and colon
is most likely a major contributor to D-IBS. CGRP and






−0.696 0.096 −0.668 −7.245 <0.0001
Excluded Variables: 5-HT of




–.126a −1.2 0.234 −0.148 0.769
NPY of
hypothalamus
.136a 1.285 0.203 0.159 0.755
NPY of colon .173a 1.701 0.094 0.208 0.798
AWR1 X is CGRP of spinal cord 0.556 0.309 0.299 Y = 0.624-0.015X (Constant) 0.624 0.05 12.403 <0.0001
CGRP of
spinal cord
−0.015 0.003 −0.556 −5.398 <0.0001
AWR2 X is CGRP of spinal cord 0.627 0.394 0.384 Y = 1.069-0.023X (Constant) 1.069 0.063 16.993 <0.0001
CGRP of
spinal cord
−0.023 0.003 −0.627 −6.494 <0.0001
AWR3 X is CGRP of spinal cord 0.657 0.432 0.423 Y = 1.48-0.03X (Constant) 1.48 0.076 19.557 <0.0001
CGRP of
spinal cord
−0.03 0.004 −0.657 −7.034 <0.0001
AWR4 X is CGRP of spinal cord 0.633 0.4 0.391 Y = 1.73-0.03X (Constant) 1.73 0.082 21.21 <0.0001
CGRP of
spinal cord
−0.03 0.005 −0.633 −6.585 <0.0001
AWR3 X is 5-HT of spinal cord 0.333 0.111 0.098 Y = 1.244-0.002X (Constant) 1.244 0.1 12.461 <0.0001
5-HT of spinal
cord
−0.002 0.001 −0.333 −2.851 0.006
AWR4 X is 5-HT of spinal cord 0.295 0.087 0.073 Y = 1.47-0.001X (Constant) 1.47 0.106 13.853 <0.0001
5-HT of spinal
cord
−0.001 0.001 −0.295 −2.49 0.015
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NPY affects IBS development possibly via indirect action
through 5-HT.
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